Xiao Xianjin, Wu Tongbo, Xu Lei, Chen Wei, Zhao Meiping
Beijing National Laboratory for Molecular Sciences and MOE Key Laboratory of Bioorganic Chemistry and Molecular Engineering, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
Family Planning Research Institute/Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Nucleic Acids Res. 2017 Jun 2;45(10):e90. doi: 10.1093/nar/gkx117.
Genetic mutations are important biomarkers for cancer diagnostics and surveillance. Preferably, the methods for mutation detection should be straightforward, highly specific and sensitive to low-level mutations within various sequence contexts, fast and applicable at room-temperature. Though some of the currently available methods have shown very encouraging results, their discrimination efficiency is still very low. Herein, we demonstrate a branch-migration based fluorescent probe (BM probe) which is able to identify the presence of known or unknown single-base variations at abundances down to 0.3%-1% within 5 min, even in highly GC-rich sequence regions. The discrimination factors between the perfect-match target and single-base mismatched target are determined to be 89-311 by measurement of their respective branch-migration products via polymerase elongation reactions. The BM probe not only enabled sensitive detection of two types of EGFR-associated point mutations located in GC-rich regions, but also successfully identified the BRAF V600E mutation in the serum from a thyroid cancer patient which could not be detected by the conventional sequencing method. The new method would be an ideal choice for high-throughput in vitro diagnostics and precise clinical treatment.
基因突变是癌症诊断和监测的重要生物标志物。理想情况下,突变检测方法应简单直接、高度特异,且对各种序列背景下的低水平突变敏感,快速且可在室温下应用。尽管目前一些可用方法已显示出非常令人鼓舞的结果,但其区分效率仍然很低。在此,我们展示了一种基于分支迁移的荧光探针(BM探针),它能够在5分钟内识别丰度低至0.3%-1%的已知或未知单碱基变异的存在,即使在高度富含GC的序列区域也是如此。通过聚合酶延伸反应测量各自的分支迁移产物,确定完美匹配靶标与单碱基错配靶标之间的区分因子为89-311。BM探针不仅能够灵敏检测位于富含GC区域的两种EGFR相关点突变,还成功鉴定出一名甲状腺癌患者血清中的BRAF V600E突变,而传统测序方法无法检测到该突变。这种新方法将是高通量体外诊断和精确临床治疗的理想选择。